News Release

EMBARGOED NEJM Catalyst TOC, August 21, 2024

Peer-Reviewed Publication

NEJM Group

Contact NEJM Group Media Relations (mediarelations@nejm.org) if you’d like to receive full-text articles and author contact information for the articles listed below.

Embargoed Until 9 AM ET on Wednesday, August 21

The African American Transplant Access Program: Mitigating Disparities in Solid Organ Transplantation
D. Simpson

The Journey to an Incentive-Based Health Equity Quality Index (Embargo lifted August 14)
E. Cheng

A Physician-Created Platform to Speed Clinical Decision-Making and Referral Workflow
E. Cunningham

How a Robust Community Clinical Practice Arm Can Support an Academic Health System’s Tripartite Mission
L. Fiscus

Comparable Real-World Patient-Reported Outcomes Data Across Health Conditions, Settings, and Countries: The PROMIS International Collaboration
C. Terwee

Longitudinal Care Management for Diabetes and Hypertension
E. Auger

Quality and Patient Safety Improvement Is Never Finished
Expert advisors: Allen Kachalia, Johns Hopkins Medicine; Kris Vanhaecht, Leuven Institute for Healthcare Policy

Novel Approaches and Actionable Insights to Improve Outcomes

About NEJM Catalyst 

NEJM Catalyst Innovations in Care Delivery is a peer-reviewed journal from NEJM Group and the publishers of the New England Journal of Medicine. The mission of the journal is to accelerate the transformation of health care delivery and improve patient health by publishing authoritative and actionable content for health care leaders, practitioners, and researchers. This journal is charting new territory through its purpose to identify the highest impact innovations, ideas, and measures to transform health care delivery.


Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.